Skip to main content
. 2021 Apr 30;11(13):6632–6643. doi: 10.7150/thno.57706

Figure 1.

Figure 1

EGFR inhibition blocks tumor cell cluster formation. A. Clustering images (left panels) and curve analyses (right panels) of tumor cells from L2G-TN1 PDXs in the presence of IgG or anti-EGFR antibody LA1 during clustering assays (n = 5, ****p < 0.0001 at the end point). B. Clustering images (left panels) and curve analyses (right panel) of tumor cells from L2T-TN2 PDXs in the presence of IgG, LA1, and cetuximab during clustering assays. C. Clustering images (left panels) and curve analyses (right panels) of tumor cells from L2T-TN1 PDXs in the presence of erlotinib and vehicle (Con) during clustering assays.